You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.
To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.
Vascular Access
Publication Date: March 1, 2020
Last Updated: January 31, 2023
GUIDELINE STATEMENTS
Patient First: ESKD Life-Plan
ESKD Life-Plan and Vascular Access Choice
KDOQI considers it reasonable that each patient with progressive CKD and/or with an eGFR 15-20 mL/min/1.73 m2 or already on kidney replacement therapy should have an individualized ESKD Life-Plan that is regularly reviewed, updated, and documented on their medical record. (Expert Opinion)
317606
KDOQI considers it reasonable to conduct an annual review and update of each patient’s individualized ESKD Life-Plan, together with their health care team. (Expert Opinion, )
317606
KDOQI considers it reasonable that, in addition to regular monitoring, a minimum quarterly overall review and update of each patient’s vascular access functionality, complication risks, and potential future dialysis access options be done together with their health care team. (Expert Opinion, )